Fig. 2: Combinational treatment of ovarian cancer cells with cisplatin and niraparib. | Cell Death Discovery

Fig. 2: Combinational treatment of ovarian cancer cells with cisplatin and niraparib.

From: Increased efficacy of PARP inhibitors against cisplatin-sensitive and -resistant ovarian cancer cells mediated via ATR and ATM inhibition

Fig. 2

A Graphical representation of experimental setup for B and C. B, C LC50 values of niraparib (B) or cDDP (C) in W1 and W1CR cells, pre- or combined treated with cDDP (B) or niraparib (C), both at 1 µM. Data represent means ± SD (n = 3). Statistical analysis for B and C was performed using paired t-tests. *P < 0.05.

Back to article page